cremophor el has been researched along with Local Neoplasm Recurrence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camlett, I; de Jonge, MJ; Gelderblom, H; Hennis, B; Loos, WJ; Mantel, MA; Sparreboom, A; van der Burg, ME; Verweij, J; Wilms, E | 1 |
| Brouwer, E; de Jonge, MJ; Gelderblom, H; Loos, WJ; Nooter, K; Sparreboom, A; Stoter, G; van der Burg, ME; Verweij, J | 1 |
1 trial(s) available for cremophor el and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Dose and schedule-finding study of oral topotecan and weekly cisplatin in patients with recurrent ovarian cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Glycerol; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Topotecan | 2001 |
1 other study(ies) available for cremophor el and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Modulation of cisplatin pharmacodynamics by Cremophor EL: experimental and clinical studies.
Topics: Animals; Antineoplastic Agents; Cisplatin; Dose-Response Relationship, Drug; Drug Interactions; Female; Glycerol; Hematologic Diseases; Humans; Infusions, Intravenous; Infusions, Parenteral; Mice; Neoplasm Recurrence, Local; Ovarian Neoplasms; Pharmaceutical Vehicles | 2002 |